Sean O’Leary, a professor of pediatrics and infectious diseases at the University of Colorado School of Medicine and vice chair of the American Academy of Pediatrics Committee on Infectious Diseases, pointed out that even with two doses, Moderna’s vaccine appears to protect children from serious disease. “I think we can expect that it is going to offer higher protection against the more severe outcomes, which is really our ultimate goal,” he said.